Peter Puleo, MD
Cardiovascular Disease · Bethlehem, PANPI 1427153774
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,628 of the $3,961 with a category attached, or 66.4%. 5 manufacturers reported payments, led by Heartflow, Inc. at 41.1% of the total. 2025 is the largest year on record at $1,947, 3.0 times the $640 reported in 2019.
Across 62 payments — averaging $63.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$2K
- Edwards Lifesciences$1K
- Boston Scientific$444
- Shockwave Medical, Inc$341
- Abbott$131
Across 1 payment — averaging $2258.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$2K
What the payments were for
- Travel & lodging$1,33234%
- Food & beverage$2,62866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 7 | $1,626 |
| Edwards Lifesciences | 24 | $1,419 |
| Boston Scientific | 21 | $444 |
| Shockwave Medical, Inc | 8 | $341 |
| Abbott | 2 | $131 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,961 in reported general payments places this provider in the 70th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 40 | $39,055 |
| XareltoRivaroxaban | 27 | $30,692 |
| EliquisApixaban | 33 | $29,483 |
| BrilintaTicagrelor | 18 | $12,100 |
| Atorvastatin Calcium | 141 | $1,690 |
| Metoprolol Succinate | 102 | $1,411 |
| Rosuvastatin Calcium | 56 | $963 |
| Ezetimibe | 47 | $680 |
| Lisinopril | 67 | $437 |
| Warfarin Sodium | 39 | $391 |
| Carvedilol | 31 | $390 |
| Amlodipine Besylate | 77 | $333 |
| Losartan Potassium | 21 | $327 |
| Nitroglycerin | 18 | $323 |
| Metoprolol Tartrate | 72 | $315 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bethlehem
- David AllenBethlehem$352K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.